← Eichor
Condition: Myelopathy Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Myelopathy

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Cycling-Based Priming Coordination Training for Enhancing Ataxia Recovery and Brain Plasticity
NA · 1 location(s) · Chang Gung University · NCT06600269Non-invasive Brain Stimulation and Exercise Intervention for Patients With Motor Neuron Disease
NA · 1 location(s) · Chulalongkorn University · NCT07067229Activity Levels in Bone Marrow Transplant Patients
Phase N/A · 1 location(s) · Michael Tomasson · NCT04115241Clinical Research in ALS Study
Phase N/A · 1 location(s) · University of Miami · NCT00136500Phase I/II Clinical Trial of Axatilimab, a CSF1R Monoclonal Antibody, in Combination With Ruxolitinib as Therapy for Pat
Phase 1/Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT07128381The Therapeutic Effect of Betaine in Syringomyelia
Phase 2 · 1 location(s) · Xuanwu Hospital, Beijing · NCT06308367Thiotepa-Containing Conditioning Regimen for Allogeneic HSCT in Chronic Myelomonocytic Leukemia
NA · 1 location(s) · Peking University People's Hospital · NCT07588594TGRX-678 US Phase I for Subjects with Refractory or Advanced Chronic Myelogenous Leukemia
Phase 1 · 2 location(s) · Shenzhen TargetRx Co., Ltd. · NCT06088888Exciflex for Chronic Wound Therapy
NA · 1 location(s) · VA Office of Research and Development · NCT04887688Ivosidenib (IVO) Monotherapy and Azacitidine (AZA) Monotherapy in Patients With Hypomethylating Agent (HMA) Naive Myelod
Phase 3 · 62 location(s) · Institut de Recherches Internationales Servier · NCT06465953MCW Alpha/Beta T-Cell and B-Cell Depletion With Targeted ATG Dosing
NA · 1 location(s) · Medical College of Wisconsin · NCT05794880Study of LX2006 Gene Therapy in Friedreich Ataxia Cardiomyopathy
Phase 2 · 1 location(s) · Lexeo Therapeutics · NCT07721025Methods of T Cell Depletion Trial (MoTD)
Phase 2 · 17 location(s) · University of Birmingham · NCT04888741Molecular Biology of Polycythemia and Thrombocytosis
Phase N/A · 1 location(s) · University of Utah · NCT00722527I Can Move With Purpose Now! A Pilot Lifestyle Intervention Study in Myeloproliferative Neoplasm Patients
NA · 3 location(s) · Massachusetts General Hospital · NCT05842603The Effect of a Muscle-mimicking, Fabric-type Shoulder Orthosis on Functional Movements of the Upper Limb in Patients Wi
NA · 1 location(s) · Seoul National University Hospital · NCT06363357NIRS MONITORING OF SPINAL CORD ISCHEMIA IN AORTIC SURGERY
Phase N/A · 1 location(s) · Monaldi Hospital · NCT07541612MindEx: A Novel, Multifocal, Cognitive Brain-Machine Interface System
NA · 1 location(s) · Nader Pouratian · NCT05936619Venetoclax to Improve Outcomes of Fractionated Busulfan Regimen in Patients With High-Risk AML and MDS
Phase 2/Phase 3 · 1 location(s) · M.D. Anderson Cancer Center · NCT04708054Clinical Study to Evaluate the Efficacy and Safety of FB1006 in the Treatment of ALS Patients
Phase 4 · 1 location(s) · Peking University Third Hospital · NCT05923905Neurostimulation for Respiratory Function After Spinal Cord Injury
NA · 1 location(s) · Shirley Ryan AbilityLab · NCT05756894Evaluation of Tranexamic Acid in Myelodysplastic Syndromes and Acute Myeloid Leukemia
Phase 2 · 1 location(s) · University of Manitoba · NCT06599762Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP
Phase 2 · 24 location(s) · Novartis Pharmaceuticals · NCT07354074Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute M
Phase 1 · 22 location(s) · National Cancer Institute (NCI) · NCT06484062Ferroptosis Study in SF3B1-mutant Myelodysplastic Syndromes (FerMDS)
NA · 3 location(s) · University Hospital, Bordeaux · NCT05924074Virtual Peer Coaching in Manual Wheelchair Skills
NA · 1 location(s) · University of Pittsburgh · NCT06295146Study to Evaluate the Pharmacokinetics and Safety of Oral Decitabine and Cedazuridine in Cancer Patients With Hepatic Im
Phase 1 · 22 location(s) · Taiho Oncology, Inc. · NCT04953910A Study of Roginolisib in Combination With Ruxolitinib in Patients With Myelofibrosis (MF) Who Are Unresponsive to JAK I
Phase 1/Phase 2 · 12 location(s) · iOnctura · NCT06887803Acute Infectious Encephalitis and Myelitis in Guadeloupe by New Generation Sequencing
Phase N/A · 1 location(s) · Centre Hospitalier Universitaire de la Guadeloupe · NCT07251049MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myel
Phase N/A · 2 location(s) · MPN Research Foundation · NCT07362225
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.